Literature DB >> 30031297

Electroclinical features of seizures associated with autoimmune encephalitis.

Claude Steriade1, Ahsan N V Moosa2, Stephen Hantus2, Richard A Prayson3, Andreas Alexopoulos2, Alexander Rae-Grant4.   

Abstract

PURPOSE: We sought to characterize the electroclinical features of seizures associated with autoimmune encephalitis and their relevance to outcome.
METHODS: 19 patients with seizures and autoimmune encephalitis were identified from a database of 100 patients (2008-2017) with autoimmune neurological disorders. Clinical and electroclinical characteristics were collected. Persistent seizures at last follow-up were then correlated with electroclinical features.
RESULTS: Status epilepticus (53%) and early intractability to AEDs (median time to second AED 9.5 days) marked the onset of refractory seizures (median number of AEDs 3). Seizure semiology (abdominal (16%), psychic (42%), olfactory (6%) auras), interictal temporal epileptiform discharges (42%), and ictal onset in the temporal region (63%) mirrored radiologic involvement of the medial temporal regions (on MRI in 74% and/or FDG-PET in 75%). In addition, multimodal auras, with somatosensory (26%), autonomic (26%), gustatory (11%), and visual (16%), features were seen in 82% of patients with focal aware seizures, invoking broader involvement of the perisylvian regions. A change in seizure semiology and EEG findings was often seen. Electroclinical features were similar regardless of antibody type, with the exception of the association of faciobrachial dystonic seizures with LGI1 antibodies. Eight patients had medically intractable seizures at last follow-up and were more likely than patients with seizure remission to have generalized tonic-clonic seizures and temporal lobe involvement on the basis of semiological features, interictal EEG and MRI changes.
CONCLUSIONS: Seizures associated with autoimmune encephalitis exhibit common electroclinical features which show dynamic evolution over time. We propose a role for the temporo-perisylvian regions in their generation.
Copyright © 2018 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibodies; Autoimmune encephalitis; EEG; Limbic encephalitis; Seizure

Mesh:

Substances:

Year:  2018        PMID: 30031297     DOI: 10.1016/j.seizure.2018.06.021

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  13 in total

Review 1.  Diagnosing autoimmune limbic encephalitis.

Authors:  Adrian Budhram; Andrew Leung; Michael W Nicolle; Jorge G Burneo
Journal:  CMAJ       Date:  2019-05-13       Impact factor: 8.262

2.  Perisylvian vulnerability to postencephalitic epilepsy.

Authors:  Claude Steriade; Lara Jehi; Balu Krishnan; Marcia Morita-Sherman; Ahsan N V Moosa; Stephen Hantus; Patrick Chauvel
Journal:  Clin Neurophysiol       Date:  2020-05-11       Impact factor: 3.708

Review 3.  Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients.

Authors:  Pierpaolo Turcano; Gregory S Day
Journal:  Curr Opin Neurol       Date:  2022-06-01       Impact factor: 6.283

4.  Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.

Authors:  Yan Wang; Yi Yu; Yaping Hu; Ying Li; Fan Song; Ying Wang
Journal:  Front Neurol       Date:  2020-05-05       Impact factor: 4.003

Review 5.  Seronegative limbic encephalitis manifesting as subacute amnestic syndrome: a case report and review of the literature.

Authors:  Ismail Ibrahim Ismail; Fahad Alnaser; Jasem Y Al-Hashel
Journal:  J Med Case Rep       Date:  2021-03-24

6.  EEG Contribution to the Diagnosis of Antibody-Negative Autoimmune Encephalitis: A Case Report.

Authors:  Mayusa Mito; Kotaro Sakurai; Yuichi Nakamura; Azusa Nagai; Sho Seo; Keiko Tanaka; Ichiro Yabe; Ichiro Kusumi
Journal:  Case Rep Neurol       Date:  2021-11-18

7.  Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data.

Authors:  Anna Rada; Robert Birnbacher; Claudio Gobbi; Martin Kurthen; Albert Ludolph; Markus Naumann; Ulrike Neirich; Tim J von Oertzen; Gerhard Ransmayr; Matthias Riepe; Mareike Schimmel; Oliver Schwartz; Rainer Surges; Christian G Bien
Journal:  J Neurol       Date:  2020-10-06       Impact factor: 4.849

Review 8.  Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis.

Authors:  Manon Bordonne; Mohammad B Chawki; Matthieu Doyen; Aurelie Kas; Eric Guedj; Louise Tyvaert; Antoine Verger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-07       Impact factor: 10.057

Review 9.  Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.

Authors:  Hesham Abboud; John C Probasco; Sarosh Irani; Beau Ances; David R Benavides; Michael Bradshaw; Paulo Pereira Christo; Russell C Dale; Mireya Fernandez-Fournier; Eoin P Flanagan; Avi Gadoth; Pravin George; Elena Grebenciucova; Adham Jammoul; Soon-Tae Lee; Yuebing Li; Marcelo Matiello; Anne Marie Morse; Alexander Rae-Grant; Galeno Rojas; Ian Rossman; Sarah Schmitt; Arun Venkatesan; Steven Vernino; Sean J Pittock; Maarten J Titulaer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-01       Impact factor: 10.154

10.  Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.

Authors:  Tao-Ran Li; Yu-Di Zhang; Qun Wang; Xiao-Qiu Shao; Rui-Juan Lv
Journal:  CNS Neurosci Ther       Date:  2021-07-22       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.